[Alpha- and beta-blocker combination in cardiovascular pathology].
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D010673:Pheochromocytoma / Q000150:complications*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists
Association alpha et bêta-bloqueurs en pathologie cardio-vasculaire